Feixia Wang
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Epidemiology 19
- Liver Disease Diagnosis and Treatment 16
- Autophagy in Disease and Therapy 3
- Hepatology 15
- Liver physiology and pathology 11
- Co-authors
- Jiangjuan Shao (32 shared papers)Shizhong Zheng (31 shared papers)Zili Zhang (25 shared papers)Feng Zhang (15 shared papers)Shanzhong Tan (14 shared papers)Yan Jia (7 shared papers)Mengmeng Li (5 shared papers)Anping Chen (5 shared papers)
- Journals
- International Immunopharmacology (2 papers)IUBMB Life (2 papers)British Journal of Pharmacology (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feixia Wang
41 papers receiving 1.3k citations
Feixia Wang's Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 253
- Cancer Research 243
- Epidemiology 319
- Pharmacology 77
- Molecular Biology 502
Countries citing papers authored by Feixia Wang
This map shows the geographic impact of Feixia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feixia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feixia Wang more than expected).
Fields of papers citing papers by Feixia Wang
This network shows the impact of papers produced by Feixia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feixia Wang. The network helps show where Feixia Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feixia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 138 | |
| 2 | 2018 | 129 | |
| 3 | Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex Hit paper breakdown → | 2023 | 91 |
| 4 | 2020 | 90 | |
| 5 | 2020 | 75 | |
| 6 | 2017 | 61 | |
| 7 | 2022 | 50 | |
| 8 | 2023 | 49 | |
| 9 | 2019 | 46 | |
| 10 | 2019 | 44 | |
| 11 | 2020 | 42 | |
| 12 | 2020 | 41 | |
| 13 | 2021 | 39 | |
| 14 | 2022 | 35 | |
| 15 | 2017 | 33 | |
| 16 | 2020 | 28 | |
| 17 | 2023 | 27 | |
| 18 | 2019 | 25 | |
| 19 | 2023 | 23 | |
| 20 | 2022 | 22 |
About Feixia Wang
Feixia Wang is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and Immunology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (11 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (3 papers), Autophagy in Disease and Therapy (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Hepatology (253 citations), Cancer Research (243 citations), Epidemiology (319 citations), Pharmacology (77 citations) and Molecular Biology (502 citations). Feixia Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiangjuan Shao, Shizhong Zheng, Zili Zhang, Feng Zhang, Shanzhong Tan, Yan Jia, Mengmeng Li, Anping Chen, Anping Chen and Siwei Xia. Their work appears in journals such as International Immunopharmacology, IUBMB Life, British Journal of Pharmacology, Journal of Cellular and Molecular Medicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.